This article is a distillation of the paper produced by the 99% Organisation NHS Project team, which included former NHS consultants, management consultants, social workers and patients with extensive experience of the NHS. The full paper is available here:
There is a petition to sign here: https://petition.parliament.uk/petitions/592557
Without significant amendment, the Health and Care Bill poses significant risks to the efficiency, effectiveness and accessibility of the NHS as a universal health service free at the point of use:
- the Bill creates enormous powers for ministers and Integrated Care Boards without corresponding duties and adequate safeguards;
- from the perspective of patients and taxpayers, the US healthcare system is a very poor performer. Nevertheless, although it is the least efficient, effective and accessible in the developed world, the US system appears to be the model towards which this Bill is moving the NHS. To our concern, we note that there is an enormous commercial incentive to do so;
- several members of the current Cabinet have made it clear that they do not wish to see the NHS continue in anything like its current form and have made proposals that would move the NHS towards the US system. Commercial interests are legally bound favour such a move. There are thus powerful motivations to erode two of the fundamental principles of the NHS: that it is free at the point of use and that it is governed on behalf of UK patients and taxpayers;
- the Bill should be amended to protect the efficiency, effectiveness and accessibility of the NHS for the UK population.
Power without responsibility or scrutiny
The Bill concentrates power over the NHS into two sets of hands: those of ministers and the Integrated Care Boards (ICBs).
To ministers, the Bill gives enhanced powers to circumvent normal procurement rules (e.g. advertising and competitive tendering) and to award contracts at will. During COVID we have seen use of emergency procurement procedures in ways which are, at best, a sub-optimal use of public money – for example with personal protective equipment (PPE) and with test and trace. In the case of PPE, well over £1 Billion of public money was spent with inexperienced suppliers and a significant proportion of what was delivered was not usable in practice. In the case of test and trace, which is costing £37 Billion of public money, the National Audit Office (NAO) has published two highly critical reports about its lack of effectiveness. Both of these are currently the subject of judicial review. Without amendment, the Bill would enable ministers to procure in this way routinely and without scrutiny.
The Bill also gives ministers the power to amend or abolish existing bodies, create new NHS trusts and to intervene in reconfigurations of NHS. Without amendment, the Bill would enable them to restructure the NHS at will without consulting Parliament.
Finally, unless the Bill is amended, there will no longer be a statutory duty on any body to arrange provision of secondary (i.e., hospital) medical services – only a power for ICBs to do so.
Such a concentration of power without responsibility or scrutiny would be inappropriate for any government whether well disposed towards the NHS or otherwise.
Risks of moving towards the US system
The US healthcare system appears to be the model towards which the NHS is being steered. And this is curious because the US system is not a high performer either in comparison with the NHS or with other systems around the world.
As patients and as taxpayers, there are three dimensions on which we would like to see the NHS perform well:
- efficiency – as taxpayers, we would like the NHS to provide a high-quality healthcare service to the UK population as cheaply as possible;
- effectiveness – as patients, we would like the NHS to provide good healthcare outcomes; and
- accessibility – as patients, we would like the NHS to be accessible geographically, temporally (i.e. without long waiting lists) and, of course, financially.
For efficiency, we can measure the number of people served per $10,000 spent. For effectiveness, there is no perfect measure, but life expectancy is a reasonable, if crude, proxy.
As the chart below shows, in terms of efficiency and effectiveness, the UK system is a good mid-range performer; the US system is the stand-out poor performer.
Figure 1: Comparison of Healthcare Systems
In addition to these considerations there is also accessibility. The US system is prohibitively expensive for those without insurance, and, even for those with insurance, it can often be ruinous. Two thirds of American personal bankruptcies are as a result of medical Bills.
Given this, it is initially surprising that the US system might be a favoured destination. But there is a fourth dimension, which is not a concern to UK taxpayers or patients but is vitally important to other stakeholders: profit. The US system is particularly good as a profit generator. Our estimates suggest that the profit opportunity available to healthcare corporations if the UK adopted the US system is of the order of $28 Billion per annum.
The risk to the UK, therefore, is that because of the size of the prize, the interests of healthcare corporations will trump those of UK taxpayers and patients at enormous cost to their lives and livelihoods.
Inclination to change the nature of the NHS
Given the concentration of power in the hands of ministers and ICBs, we are concerned about their motivations when it comes to steering and governing the NHS.
John Major commented in 2016:
“The concept that [the Cabinet] would care for the National Health Service is a rather odd one: Michael Gove wanted to privatise it; Boris wanted to charge people for using it; and Iain Duncan Smith wanted a social insurance system. The NHS is about as safe with them as a pet hamster would be with a hungry python.”
The Health Secretary, Sajid Javid, has celebrated his adherence to the ideas of Ayn Rand who vehemently opposed the very idea of publicly funded healthcare. In an extraordinary speech to the Conservative Party Conference, Javid rejected the fundamental principle of a National Health Service as a citizen’s first line of defence against illness or injury:
“The state was needed in this pandemic more than at any time in peacetime. But government shouldn’t own all risks and responsibilities in life. We, as citizens, have to take some responsibility for our health too. We shouldn’t always go first to the state – what kind of society would that be? Health and Social Care: it begins at home. It should be family first, then the community then the state.”
On the corporate side, as drafted, the Bill will allow corporate members to sit on the ICBs (and indeed this has already started to happen) and therefore to play an important role in the governance of the NHS. Directors of corporations have a fiduciary duty to the members of their company – i.e. to their shareholders. Where there is a conflict of interest between taxpayers, patients and company shareholders, the corporate members are legally bound to favour their shareholders. And as noted above there is an enormous commercial incentive to steer the NHS towards the US system.
This evidence that this Bill, as it stands, will introduce conflicting motivations within NHS governance highlights the need for amendment to add checks and balances to the Bill.
Amendments needed to the Bill
For the reasons stated above, without amendment, the Bill poses a grave risk to the NHS itself and to UK taxpayers and patients.
Others have proposed more comprehensive lists of amendments; the table below summarises what we believe to be the most important amendments needed.
|What the Bill does||What it should do: Amendments Needed|
|The Bill removes the obligation for public tendering for NHS services and allows ministers to circumvent normal procurement rules.||The Government should protect the NHS from unnecessary and costly private sector involvement and ensure scrutiny and transparency over the awarding of contracts. The most effective way of doing that is to make the NHS the default option for NHS contracts and to tender competitively where this is not possible.|
|The legislation leaves open the possibility for corporate healthcare providers to gain seats on ICS boards which represents a clear conflict of interest and gives them undue influence in decision-making.||Keep governance under the control of those whose fiduciary duty is to patients and to the NHS rather than to shareholders.|
|There will no longer be a statutory duty on any body to arrange provision of secondary (i.e., hospital) medical services – only a power for ICBs to do so.
Gives new and considerable powers to amend or abolish existing arm’s length bodies, create new NHS trusts and to intervene in reconfigurations of the health service.
|Reintroduce a duty on the Health Secretary to provide a high-quality health and care service, free at the point of use for all UK citizens.
Introduce a statutory duty on the ICBs to ensure provision of secondary medical services
Ensure adequate funding to meet the needs of the population.
|Gives ministers greater control over patient data.||Impose strict protection on patient data unless totally anonymised (not merely de-personalised) especially when given or sold to commercial organisations.|
If you would like to see the Bill amended, please sign the petition.
And if you are not already a member, please join the 99% Organisation.
Armstrong, R. (1982, 9 6). Longer Term Options. Retrieved from https://99-percent.org/: https://99-percent.org/wp-content/uploads/2021/07/Longer-Term-Options-Cabinet-Paper.pdf
BSW Partnership Board . (2021, 5 28). BSW Partnership Board . Retrieved from https://bswpartnership.nhs.uk/: https://bswpartnership.nhs.uk/wp-content/uploads/BSW-Partnership-Board-meeting-28-May-2021-combined-papers.pdf
Gove, M., Kwarteng, K., Norman, J., Hunt , J., Penrose, J., Carswell, D., & Hannan , D. (2015). Direct Democracy: An Agenda for a New Model Party. Retrieved from https://whatwouldvirchowdo.files.wordpress.com/: https://whatwouldvirchowdo.files.wordpress.com/2015/09/direct_democracy___an_agenda_for_a_new_model_party.pdf
Harrington, D., Beetham , H., & Matthews, S. (2021, 5). NHS BILL 2021. Retrieved from https://publicmatters.org.uk/: https://publicmatters.org.uk/wp-content/uploads/2021/05/Public-Matters-BRIEFING-NHS-BILL-FINAL.pdf
Himmelstein, D. U., Lawless, R. M., Thorne, D., Foohey, P., & Woolhandler, S. (2018, 11 17). Medical Bankruptcy: Still Common Despite the Affordable Care Act. Retrieved from https://ajph.aphapublications.org/: https://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2018.304901?journalCode=ajph&
Hoskin, P. (2015, 1 15). Javid: “I read the courtroom scene from ‘The Fountainhead’ to my future wife!”. Retrieved from https://www.conservativehome.com/parliament/: https://www.conservativehome.com/parliament/2015/01/javid-i-read-the-courtroom-scene-from-the-fountainhead-to-my-future-wife.html
Mason, R. (2016, 6 5). John Major: NHS at risk from Brexit ‘pythons’ Johnson and Gove. Retrieved from https://www.theguardian.com/: https://www.theguardian.com/politics/2016/jun/05/john-major-nhs-risk-brexit-pythons-johnson-and-gove
Pollock, M. A., & Roderick, P. (2021, 9 25). Health and Care Bill 2021-22. Retrieved from https://allysonpollock.com/: https://allysonpollock.com/?p=3690
Redwood, O. L. (1988). Britain’s Biggest Enterprise. Retrieved from https://www.scribd.com/: https://www.scribd.com/doc/56986348/Britain-s-Biggest-Enterprise
The 99% Organisation. (2021, 09 01). Protecting the NHS from Destructive Reform. Retrieved from https://99-percent.org/: https://99-percent.org/wp-content/uploads/2021/09/NHS-Fact-pack-v1.6.pdf
Thomas, M. E. (2020, 9 1). Money for Nothing? Retrieved from https://99-percent.org/: https://99-percent.org/money-for-nothing/
Thomas, M. E. (2021, 4 13). What’s in a Name? Retrieved from https://99-percent.org/: https://99-percent.org/whats-in-a-name/
Tonkin, T. (2021, 7 7). Health and Care Bill: BMA demands greater protection for patients and NHS. Retrieved from https://www.bma.org.uk/: https://www.bma.org.uk/news-and-opinion/health-and-care-bill-bma-demands-greater-protection-for-patients-and-nhs
 (Pollock & Roderick, 2021)
 (Thomas, 2020)
 (Thomas, What’s in a Name?, 2021)
 (Harrington, Beetham , & Matthews, 2021)
 (Himmelstein, Lawless, Thorne, Foohey, & Woolhandler, 2018)
 (The 99% Organisation, 2021)
 (Mason, 2016)
 (Hoskin, 2015)
 (Gove, et al., 2015)
 (Redwood, 1988)
 (Armstrong, 1982)
 (BSW Partnership Board , 2021)
 E.g. (Pollock & Roderick, 2021) and (Tonkin, 2021)